Intrinsic Value of S&P & Nasdaq Contact Us

Brookdale Senior Living Inc. BKD NYSE

NYSE • Healthcare • Medical - Care Facilities • US • USD

SharesGrow Score
41/100
1/7 Pass
SharesGrow Intrinsic Value
$1,048.83
+7434.7%
Analyst Price Target
$17.50
+25.7%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Brookdale Senior Living Inc. (BKD) has a negative trailing P/E of -12.3, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 178.5 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -8.15%, forward earnings yield 0.56%. PEG 0.59 (Peter Lynch undervalued ≤1.0).

Criteria proven by this page:

  • VALUE (90/100, Pass) — PEG ≤ 1.0 — Peter Lynch undervalued (0.59); analyst target implies upside (+25.7%).
  • Forward P/E 178.5 — analysts expect a return to profitability with estimated EPS of $0.08 for FY2027.
  • PEG Ratio 0.59 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
  • Trailing Earnings Yield -8.15% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 0.56% as earnings recover.
  • Analyst consensus target $17.50 (+25.7% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 41/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score
41/100
SG Score
View full scorecard →
VALUE
90/100
Price-to-Earnings & upside
Proven by this page
~
FUTURE
58/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
49/100
→ Income
GROWTH
30/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — BKD

Valuation Multiples
P/E (TTM)-12.3
Forward P/E178.5
PEG Ratio0.59
Forward PEG0.59
P/B Ratio-72.05
P/S Ratio1.05
EV/EBITDA25.0
Per Share Data
EPS (TTM)$-1.12
Forward EPS (Est.)$0.08
Book Value / Share$-0.19
Revenue / Share$13.34
FCF / Share$0.07
Yields & Fair Value
Earnings Yield-8.15%
Forward Earnings Yield0.56%
Dividend Yield0.00%
SharesGrow IV$1,048.83 (+7434.7%)
Analyst Target$17.50 (+25.7%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 -5.7 0.47 1.11 0.54 -
2017 -3.2 -0.08 1.18 0.47 -
2018 -2.4 0.29 1.23 0.36 -
2019 -5.0 0.10 1.94 0.33 -
2020 9.9 -0.08 1.02 0.27 -
2021 -9.6 0.04 1.37 0.35 -
2022 -2.2 -0.02 0.89 0.19 -
2023 -6.9 0.21 3.25 0.46 -
2024 -5.7 -0.95 5.39 0.38 -
2025 -9.6 -0.39 -56.50 0.81 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $-2.18 $4.98B $-404.4M -8.1%
2017 $-3.07 $4.75B $-571.42M -12%
2018 $-2.82 $4.53B $-528.26M -11.7%
2019 $-1.44 $4.06B $-268.49M -6.6%
2020 $0.44 $3.42B $82.02M 2.4%
2021 $-0.54 $2.75B $-99.36M -3.6%
2022 $-1.25 $2.74B $-238.34M -8.7%
2023 $-0.84 $3.01B $-189.01M -6.3%
2024 $-0.89 $3.13B $-201.94M -6.5%
2025 $-1.11 $3.12B $-262.69M -8.4%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $-0.21 $-0.21 – $-0.21 $3.02B $3.01B – $3.03B 2
2027 $0.07 $0.07 – $0.07 $3.12B $3.11B – $3.13B 2
2028 $0.32 $0.31 – $0.32 $3.27B $3.26B – $3.28B 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message